WeVote

Bill

Bill

HB 4813

Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration with respect to those substances.

89th Legislature (2025) Introduced by Aicha Davis and 2 co-sponsors

Texas bill authorizes automatic state drug scheduling changes when FDA acts, streamlining policy alignment but potentially reducing legislative oversight of controlled substance classifications.

Referred to Health & Human Services
0
WeVote Research Nonpartisan
Bill Summary · HB 4813

Legislative bill overview

HB 4813 establishes a mechanism for Texas to automatically adjust its controlled substance scheduling in response to changes made by the U.S. Food and Drug Administration. The bill allows the state to align its drug classification system with federal FDA actions without requiring separate legislative approval for each adjustment.

Why is this important

This streamlines drug policy implementation by reducing bureaucratic lag between federal and state regulatory changes. It affects law enforcement priorities, criminal penalties, medical access to certain substances, and research capabilities, making drug policy responsive to evolving scientific and medical evidence.

Potential points of contention

  • Autonomy concerns: Critics may argue this delegates state legislative authority to federal agencies, reducing Texas lawmakers' direct control over criminal drug scheduling decisions
  • Unintended consequences: Automatic alignment could inadvertently expand or restrict access to substances faster than the state legislature intended, affecting sentencing guidelines and medical practice
  • Public involvement: The automatic mechanism may bypass public comment periods and legislative debate that typically accompany significant drug policy changes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.